Avricore Health (AVCRF) Other financing activities (2012 - 2021)

Avricore Health (AVCRF) posted quarterly Other financing activities of -$718.76 for Q4 2021, up 96.11% YoY from -$366.52 in Q4 2020, and up 99.07% sequentially from -$77184.8 in Q1 2021.

Avricore Health (AVCRF) Other financing activities (2012 - 2021) Analysis & Trends

Avricore Health has disclosed Other financing activities across 9 years of filings, most recently posting -$718.76 for Q4 2021.

  • In Q4 2021, Other financing activities rose 96.11% year-over-year to -$718.76; the TTM figure through Dec 2021 stood at -$77903.5 (down 113.36% YoY), while the FY2021 annual figure was -$78675.2, down 317.54% from the prior year.
  • Other financing activities rose to -$718.76 in Q4 2021, from -$77184.8 in the prior quarter.
  • Over the last five years, Other financing activities for AVCRF reached as high as -$718.76 in Q4 2021 and fell as low as -$77184.8 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Avricore Health - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 -718.76
Dec 31, 2021 -718.76
Mar 31, 2021 -77,184.78
Mar 31, 2021 -77,184.78
Dec 31, 2020 -18,453.80
Dec 31, 2020 -18,453.80
Sep 30, 2015 -155,806.53
Sep 30, 2015 -155,806.53
Jun 30, 2015 -165,388.15
Jun 30, 2015 -165,388.15
Dec 31, 2014 922,690.60
Dec 31, 2014 922,690.60
Sep 30, 2014 -15,163.72
Sep 30, 2014 -15,163.72
Jun 30, 2014 -52,310.06
Jun 30, 2014 -52,310.06
Mar 31, 2014 181,137.83
Mar 31, 2014 181,137.83
Dec 31, 2013 -15,719.71
Dec 31, 2013 -15,719.71